NYSE:MET - Metlife Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$43.84 +0.22 (+0.50 %)
(As of 10/19/2018 04:00 PM ET)
Previous Close$43.84
Today's Range$43.05 - $44.02
52-Week Range$42.80 - $55.91
Volume6.03 million shs
Average Volume6.13 million shs
Market Capitalization$43.39 billion
P/E Ratio9.74
Dividend Yield3.85%
Beta1.23
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
SymbolNYSE:MET
CUSIP59156R10
Phone212-578-9500

Debt

Debt-to-Equity Ratio0.29
Current Ratio0.15
Quick Ratio0.15

Price-To-Earnings

Trailing P/E Ratio9.74
Forward P/E Ratio8.41
P/E Growth0.67

Sales & Book Value

Annual Sales$62.09 billion
Price / Sales0.70
Cash Flow$4.5010 per share
Price / Cash9.74
Book Value$55.94 per share
Price / Book0.78

Profitability

EPS (Most Recent Fiscal Year)$4.50
Net Income$4.01 billion
Net Margins6.12%
Return on Equity9.17%
Return on Assets0.73%

Miscellaneous

Employees49,000
Outstanding Shares994,840,000
Market Cap$43.39 billion

Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.83%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife announced that its Board of Directors has authorized a share repurchase program on Tuesday, May 22nd 2018, which allows the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 3.1% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's management believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) released its quarterly earnings results on Wednesday, August, 1st. The financial services provider reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.13. The financial services provider earned $21.22 billion during the quarter, compared to analysts' expectations of $15.65 billion. Metlife had a return on equity of 9.17% and a net margin of 6.12%. The company's quarterly revenue was up 36.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.04 earnings per share. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Thursday, November 1st 2018. View Earnings Estimates for Metlife.

How can I listen to Metlife's earnings call?

Metlife will be holding an earnings conference call on Friday, November 2nd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8772099920.

What price target have analysts set for MET?

14 Wall Street analysts have issued 12 month price targets for Metlife's stock. Their predictions range from $48.00 to $63.00. On average, they expect Metlife's stock price to reach $55.0769 in the next year. This suggests a possible upside of 25.6% from the stock's current price. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife has been significantly performing well on the back of prudent underwriting and expense management. Its efforts to streamline business, only to focus on core business are really impressive. Its revenues grew in 2017 and first half of 2018 after declining for two years and the trend is likely to continue. Its strong international operations and disciplined capital management should drive long-term growth. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins.  Shares have underperformed its industry in year. Moreover, the company has witnessed its 2018 estimates move down in the last seven days. A Zacks Rank #3 and Earnings ESP of -1.00% makes surprise prediction difficult as it reports third quarter results on Nov 1. The Zacks Consensus Estimate for third quarter is pegged at $1.26, reflecting a year-over-year increase of 15.6%." (10/12/2018)
  • 2. Wells Fargo & Co analysts commented, "We attended in Tokyo. The company provided context around its Asian business, which represents 25% of its earnings ($1.2 billion in 2017) but is expected to grow in the double-digits. Of its Asian business about 75% of its earnings comes from Japan. MET spoke optimistically about: (1) the growth prospects of the region due to its low insurance penetration, GDP growth of 4.8% in the countries MET operates in, and an aging population, and (2) its commitment to sustainable growth in cash from its Asian business (60% of its GAAP earnings are being taken out as dividends). The meeting also gave us a chance to hear from Kishore Ponnavolu, who took over as head of MET’s Asian business at the start of September. We are not changing our EPS estimates or price target at this time and do not expect a material movement in the shares following the meeting." (9/27/2018)

Who are some of Metlife's key competitors?

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)
  • Mr. Martin J. Lippert, Exec. VP and Head of Global Technology & Operations (Age 58)
  • Mr. Steven Jeffery Goulart, Exec. VP & Chief Investment Officer (Age 59)
  • Mr. Michel A. Khalaf, Pres of U.S. Bus. & EMEA (Age 54)
  • Mr. John Carroll Ramsey Hele, Sr. Adviser (Age 60)

Who are Metlife's major shareholders?

Metlife's stock is owned by many different of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.21%), State of New Jersey Common Pension Fund D (0.14%), Douglas Lane & Associates LLC (0.13%), Strs Ohio (0.09%), Deprince Race & Zollo Inc. (0.05%) and Aperio Group LLC (0.05%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris, Peter M Carlson and Steven A Kandarian. View Institutional Ownership Trends for Metlife.

Which institutional investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Strs Ohio, Douglas Lane & Associates LLC, Gofen & Glossberg LLC IL, Graybill Bartz & Assoc Ltd., Covenant Multifamily Offices LLC, Aperio Group LLC and Xact Kapitalforvaltning AB. Company insiders that have sold Metlife company stock in the last year include Christopher G Townsend and Steven A Kandarian. View Insider Buying and Selling for Metlife.

Which institutional investors are buying Metlife stock?

MET stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Benson Investment Management Company Inc., First Hawaiian Bank, Farmers Trust Co., DAVENPORT & Co LLC, Cornerstone Wealth Management LLC, Deprince Race & Zollo Inc. and Clinton Group Inc.. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $43.84.

How big of a company is Metlife?

Metlife has a market capitalization of $43.39 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.


MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  733 (Thanks for Voting!)
Underperform Votes:  453 (Thanks for Voting!)
Total Votes:  1,186
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel